Kenji Yogo - Concepedia

Author

Kenji Yogo

Chugai Pharma (United States)

Also Known As

K Yogo, K. Yogo, Kenji YOGO, Kenji Yogo

Publications

Citations

H-Index

Concepts

All Affiliations

Chugai Pharma (United States)Gunma University Kitasato Institute Hospital Tokai University Kyushu University

About

Kenji Yogo is an author at Chugai Pharma (United States) specializing in physiology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	372
2	Health Sciences	5	5	131
3	Anesthesia	2	2	38
4	Applied Physiology	1	1	49
5	Biochemistry	1	1	17

Kenji Yogo

Publications

906

Citations

H-Index

Page 1

	Year	Citations
Different Vasculoprotective Roles of NO Synthase Isoforms in Vascular Lesion Formation in Mice Kenji Yogo, Hiroaki Shimokawa, Hajime Funakoshi, Arteriosclerosis Thrombosis and Vascular Biology	2000	91
Sarpogrelate, a Selective 5-HT2A Serotonergic Receptor Antagonist, Inhibits Serotonin-Induced Coronary Artery Spasm in a Porcine Model Kenji Miyata, Hiroaki Shimokawa, Taiki Higo, Journal of Cardiovascular Pharmacology	2000	71
Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats Kenichi Serizawa, Kenji Yogo, Ken Aizawa, Cardiovascular Diabetology	2011	64
22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy Michinori Hirata, Kenichi Serizawa, Ken Aizawa, Nephrology Dialysis Transplantation	2012	61
Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo Kunio Morishige, Hiroaki Shimokawa, Tohru Yamawaki, Journal of the American College of Cardiology Translational MedicineVascular DiseasePorcine Coronary ArteriesCardiovascular DiseaseLocal Adenovirus-mediated Transfer	2000	53
Vitamin D Receptor Signaling Enhances Locomotive Ability in Mice Sadaoki Sakai, Miho Suzuki, Yoshihito Tashiro, Journal of Bone and Mineral Research Orthopaedic SurgeryOsteoporosisCellular PhysiologyOsteoporosis IncreasesKinesiology	2014	49
GM-109: a novel, selective motilin receptor antagonist in the smooth muscle of the rabbit small intestine. Hisanori Takanashi, Kenji Yogo, Kenichi Ozaki, Journal of Pharmacology and Experimental Therapeutics	1995	45
An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying Kenichi Ozaki, Mitsu Onoma, Hiroyasu Muramatsu, European Journal of Pharmacology Motilin-induced Gastrointestinal MotilityGastrointestinal PharmacologyMedicinePhysiologyFundic Tone	2009	33
In vitro Pharmacological Characterization of Mitemcinal (GM-611), the First Acid-Resistant Non-Peptide Motilin Receptor Agonist, in Smooth Muscle of Rabbit Small Intestine Hisanori Takanashi, Kenji Yogo, Kenichi Ozaki, Pharmacology Animal PhysiologyMolecular PharmacologyGastrointestinal Peptide HormoneHealth SciencesContractile Response	2006	31
Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis Kenichi Serizawa, Haruna Tomizawa-Shinohara, Mayu Magi, Journal of Neuroimmunology	2018	29

Page 1